Serial Number
98745375
Owner
DynamiCure Biotechnology, LLCAttorney
Keith Toms, Esq.Filing Date
Sep 11, 2024
DYNAMICURE Trademark
Serial Number: 98745375
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Keith Toms, Esq. McCarter & English, LLP
265 Franklin Avenue
Boston, MA 02110-3113
United States
Trademark Details
Filing Date
September 11, 2024
Registration Date
Not Registered
Published for Opposition
October 28, 2025
Goods & Services
Research and development services in the field of biologics, namely, antibodies and peptides for the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; Research and development in the pharmaceutical and biotechnology fields for the treatment of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics in the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; Conducting research for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of autoimmune diseases, autoimmune disorders, metabolic diseases, neurodegenerative diseases, and kidney diseases; All of the foregoing excluding services in the field of neuromuscular disorders and orphan diseases
Pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders, autoimmune deficiency; Pharmaceutical preparation and substances for the treatment of genetic disorders; Pharmaceutical preparations and substances for the treatment of metabolic diseases; Pharmaceutical preparations and substances for the treatment of neurodegenerative diseases; Pharmaceutical preparations and substances for the treatment of kidney diseases; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of tumors, genetic disorder and autoimmune disorders and conditions; All of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases